AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Explore various ways to earn quick money through business ventures. Start your journey toward financial success right now!
26,029 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Apple’s 2026 strategy centers on Services and cash returns, contrasting with Amazon’s AI infrastructure push, shaping...
A new Iran clash sends shockwaves through global travel, with 23,000 cancelled flights debris and mass disruptions ac...
ChangeNOW has unveiled Private Send, a new privacy feature in NOW Wallet that hides the direct link between sender an...
A new privacy framework lets bitcoin holders hide more balances and transfers by moving BTC to a shielded ERC-20 on S...
Two North American midstream giants posted earnings that point to divergent paths for dividend investors in 2026. ENB...
MISMO rolled out FRAME, a governance toolkit for AI in mortgage operations, during its Spring Summit in Louisville. T...
iQIYI’s stock trades near $1 after a disappointing Q1 report, but the company’s AI pivot and new capital moves set up...
Chip stocks were crashing after a period of strong earnings, leaving many investors puzzled. This article unpacks why...
Geopolitical tensions are lifting oil prices and sending oil stocks higher. But is this trend sustainable or a tempor...
PennantPark pays an about 20% yield through an $0.08 monthly payout, but a spillover reserve backs part of the divide...
As factories brace for a new wave of automation and infrastructure spending, the materials sector could lead gains. T...